|
|
|
|
LEADER |
00000cam a22000008i 4500 |
001 |
EBSCO_on1265346527 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
210903s2021 nyua ob 001 0 eng |
010 |
|
|
|a 2021041514
|
040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d OCLCO
|d YDX
|d OCLCF
|d VTM
|d OCLCO
|d N$T
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1265456996
|
020 |
|
|
|a 1685070833
|
020 |
|
|
|a 9781685070830
|q (electronic bk.)
|
020 |
|
|
|z 9781685070717
|q (hardcover)
|
020 |
|
|
|z 168507071X
|
035 |
|
|
|a (OCoLC)1265346527
|z (OCoLC)1265456996
|
042 |
|
|
|a pcc
|
050 |
0 |
0 |
|a RC643
|
082 |
0 |
0 |
|a 616.99/446
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Burkitt lymphoma :
|b diagnosis, risk factors and treatment /
|c Douglas V. Berthelot, editor.
|
264 |
|
1 |
|a New York :
|b Nova Science Publishers,
|c [2021]
|
300 |
|
|
|a 1 online resource (xii, 259 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Cancer etiology, diagnosis and treatments
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a "Burkitt lymphoma (BL) is a form of non-Hodgkin's lymphoma in which cancer starts in immune cells called B-cells. If left untreated, it is rapidly fatal. Chapter One of this monograph evaluates the etiology, pathological issues, diagnosis, clinical manifestations, epidemiology, research, innovation and treatment issues of BL using the clinical systematic review research method and experts' opinion analysis approach. Chapter Two reviews the spectrum, unique characteristics and special management considerations when BL develops in specific subgroups of patients with primary immune deficiency disorders. Chapter Three reviews the incidence, clinicopathological and epidemiologic features, treatment and outcome data available in pediatric and adult patients with post solid organ transplant BL. Chapter Four focuses on the pathobiology and the treatment of first-line and relapsed/refractory cases of BL and describes new therapeutic strategies which could improve results in this pathology. Chapter Five examines the therapeutic advances in BL and its variants. Finally, Chapter Six explores and emphasizes the trends and issues in research and innovation in the characteristics, clinical updates and management approaches of BL"--
|c Provided by publisher.
|
588 |
|
|
|a Description based on print version record and CIP data provided by publisher; resource not viewed.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Burkitt's lymphoma.
|
650 |
|
2 |
|a Burkitt Lymphoma
|
650 |
|
6 |
|a Tumeur de Burkitt.
|
650 |
|
7 |
|a Burkitt's lymphoma
|2 fast
|
700 |
1 |
|
|a Berthelot, Douglas V.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Burkitt lymphoma
|d New York : Nova Science Publishers, [2021]
|z 9781685070717
|w (DLC) 2021041513
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3001017
|z Texto completo
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 302419333
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 3001017
|
994 |
|
|
|a 92
|b IZTAP
|